Presentation is loading. Please wait.

Presentation is loading. Please wait.

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.

Published byBethany Chapman Modified over 6 years ago

Similar presentations

Presentation on theme: "Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M."— Presentation transcript:

1 Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M. Arnold, MD, Mahesh Kudrimoti, MD, Emily V. Dressler, PhD, John F. Gleason, MD, Natalie L. Silver, MD, William F. Regine, MD, Joseph Valentino, MD  Advances in Radiation Oncology  Volume 1, Issue 4, Pages (October 2016) DOI: /j.adro Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

2 Figure 1 Schema describing the regimen of clinical trial 02-HN-15: low-dose fractionated radiation therapy + carboplatin and paclitaxel. Solid bars represent 50 cGy fractions of radiation. SCCHN, squamous cell cancer of the head and neck. Advances in Radiation Oncology 2016 1, DOI: ( /j.adro ) Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

3 Figure 2 Overall (OS), progression-free, and disease-specific survival. Advances in Radiation Oncology 2016 1, DOI: ( /j.adro ) Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

4 eFigure 1 Advances in Radiation Oncology 2016 1, DOI: ( /j.adro ) Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

Download ppt "Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M."

Similar presentations

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.
COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.
Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes  Stuart E. Samuels, MD, PhD, Matthew.

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes  Stuart E. Samuels, MD, PhD, Matthew.
Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell.

Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell.
Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer  Victor E. Chen, BS, Erin.

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer  Victor E. Chen, BS, Erin.
Efficacy and Safety of Pemetrexed Maintenance Therapy versus Best Supportive Care in Patients from East Asia with Advanced, Nonsquamous Non-small Cell.

Efficacy and Safety of Pemetrexed Maintenance Therapy versus Best Supportive Care in Patients from East Asia with Advanced, Nonsquamous Non-small Cell.
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Abscopal effect in recurrent colorectal cancer treated with carbon-ion radiation therapy: 2 case reports  Daniel K. Ebner, BS, Tadashi Kamada, MD, PhD,

Abscopal effect in recurrent colorectal cancer treated with carbon-ion radiation therapy: 2 case reports  Daniel K. Ebner, BS, Tadashi Kamada, MD, PhD,
Incorporating big data into treatment plan evaluation: Development of statistical DVH metrics and visualization dashboards  Charles S. Mayo, PhD, John.

Incorporating big data into treatment plan evaluation: Development of statistical DVH metrics and visualization dashboards  Charles S. Mayo, PhD, John.
Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity  Sarah J. Stephens, MD, Samantha Thomas, MB,

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity  Sarah J. Stephens, MD, Samantha Thomas, MB,
Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center  Kristina D. Woodhouse, MD, Wei-Ting.

Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center  Kristina D. Woodhouse, MD, Wei-Ting.
Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions  Chelsea.

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions  Chelsea.
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.
Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy  Dawn Owen, MD, PhD, Charles S. Mayo, PhD,

Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy  Dawn Owen, MD, PhD, Charles S. Mayo, PhD,
Effect of variations in atelectasis on tumor displacement during radiation therapy for locally advanced lung cancer  Nathan Tennyson, MD, Elisabeth Weiss,

Effect of variations in atelectasis on tumor displacement during radiation therapy for locally advanced lung cancer  Nathan Tennyson, MD, Elisabeth Weiss,
A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy  William.

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy  William.
Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and.

Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and.
Tijana Skrepnik, MD, Silvija Gottesman, MD, Baldassarre Stea, MD, PhD 

Tijana Skrepnik, MD, Silvija Gottesman, MD, Baldassarre Stea, MD, PhD 
High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes  Tania Kaprealian, M.D., Vivian Weinberg, Ph.D.,

High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes  Tania Kaprealian, M.D., Vivian Weinberg, Ph.D.,
Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Similar presentations

Ads by Google